135 related articles for article (PubMed ID: 9403314)
1. Myocardial histological changes in dilated cardiomyopathy during a long-term left ventricular assist device support.
Taketani S; Sawa Y; Fukushima N; Masai T; Kawaguchi N; Onishi S; Matsuda H
Heart Vessels; 1997; 12(2):98-100. PubMed ID: 9403314
[TBL] [Abstract][Full Text] [Related]
2. Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.
Strecker T; Rösch J; Weyand M; Agaimy A
Int J Clin Exp Pathol; 2014; 7(9):5549-56. PubMed ID: 25337196
[TBL] [Abstract][Full Text] [Related]
3. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
[TBL] [Abstract][Full Text] [Related]
4. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
[TBL] [Abstract][Full Text] [Related]
5. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
[TBL] [Abstract][Full Text] [Related]
6. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
[TBL] [Abstract][Full Text] [Related]
7. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
8. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
[TBL] [Abstract][Full Text] [Related]
9. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy.
George RS; Birks EJ; Cheetham A; Webb C; Smolenski RT; Khaghani A; Yacoub MH; Kelion A
Eur J Heart Fail; 2013 Sep; 15(9):1035-43. PubMed ID: 23610136
[TBL] [Abstract][Full Text] [Related]
11. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.
Shahinian JH; Rog-Zielinska EA; Schlimpert M; Mayer B; Tholen S; Kammerer B; Biniossek ML; Beyersdorf F; Schilling O; Siepe M
Artif Organs; 2020 Mar; 44(3):257-267. PubMed ID: 31494943
[TBL] [Abstract][Full Text] [Related]
12. Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
Tansley P; Yacoub M; Rimoldi O; Birks E; Hardy J; Hipkin M; Bowles C; Kindler H; Dutka D; Camici PG
J Heart Lung Transplant; 2004 Nov; 23(11):1283-9. PubMed ID: 15539127
[TBL] [Abstract][Full Text] [Related]
13. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support.
Parikh M; Shah S; Basu R; Famulski KS; Kim D; Mullen JC; Halloran PF; Oudit GY
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216165
[TBL] [Abstract][Full Text] [Related]
15. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy.
Scheinin SA; Capek P; Radovancevic B; Duncan JM; McAllister HA; Frazier OH
ASAIO J; 1992; 38(3):M271-4. PubMed ID: 1457863
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic changes during left ventricular assist device-off test correlate with the degree of cardiac fibrosis and predict the outcome after device explantation.
Saito S; Toda K; Miyagawa S; Yoshikawa Y; Fukushima S; Sakata Y; Mizote I; Daimon T; Sawa Y
J Artif Organs; 2015 Mar; 18(1):27-34. PubMed ID: 25370718
[TBL] [Abstract][Full Text] [Related]
18. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
[TBL] [Abstract][Full Text] [Related]
19. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.
Grabellus F; Levkau B; Sokoll A; Welp H; Schmid C; Deng MC; Takeda A; Breithardt G; Baba HA
Cardiovasc Res; 2002 Jan; 53(1):124-30. PubMed ID: 11744020
[TBL] [Abstract][Full Text] [Related]
20. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy.
Küçüker SA; Stetson SJ; Becker KA; Akgül A; Loebe M; Lafuente JA; Noon GP; Koerner MM; Entman ML; Torre-Amione G
J Heart Lung Transplant; 2004 Jan; 23(1):28-35. PubMed ID: 14734124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
